Stay updated on Tolebrutinib in NRSPMS Clinical Trial

Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Standardized the India locations by replacing the diacritic spelling Gūrgaon with Gurgaon for site IDs 122001 and 122002.
    Difference
    0.0%
    Check dated 2026-03-18T03:24:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Two India study site entries were updated from Gurgaon 122001 and 122002 to Gūrgaon 122001 and 122002, and the revision was bumped to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T16:51:39.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Two new Gurgaon, India locations (122001 and 122002) were added and the Gūrgaon spellings for these entries were removed.
    Difference
    0.0%
    Check dated 2026-03-03T10:36:01.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-17T03:52:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.1 and the previous funding-lapse notice (v3.4.0) was removed.
    Difference
    0.1%
    Check dated 2026-02-09T22:41:05.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Two study location entries in India (122001 and 122002) were updated from Gurgaon to the diacritic spelling Gūrgaon in the study's locations list.
    Difference
    0.1%
    Check dated 2026-02-02T19:57:01.000Z thumbnail image

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.